1. The value of EEG attenuation in the prediction of outcome in COVID-19 patients

   • Lucio Marinelli
   • Irene Pappalardo
   • Flavio Villani

   COVID-19 Open access 27 August 2022 Pages: 6159 - 6166

   

2. Autonomic and neuropathic complaints of long-COVID objectified: an investigation from electrophysiological perspective

   • Merve Hazal Ser
   • Fatma Zehra Çalıkuşu
   • Ayşegül Gündüz

   COVID-19 22 August 2022 Pages: 6167 - 6177

   

3. Carotid free-floating thrombus during COVID-19 vaccine era: causality or not?

   • Ludovica Ferraù
   • Masina Cotroneo
   • Paolino La Spina

   Brief Communication 03 August 2022 Pages: 6179 - 6183

   

4. Hyperbaric oxygen therapy to reverse post-COVID cognitive impairment

   • Chia Siang Kow
   • Dinesh Sangarran Ramachandram
   • Syed Shahzad Hasan

   COVID-19 26 August 2022 Pages: 6185 - 6186

5. Are corticosteroids useful in the treatment of brain edema associated with venous cerebral thrombosis (CVT) in patients with COVID-19 vaccine-related CVT? A controversial topic

   • Martina Di Pietro
   • Fedele Dono
   • Stefano L. Sensi

   COVID-19 20 August 2022 Pages: 6187 - 6188

6. Psychometrics, diagnostics and usability of Italian tools assessing behavioural and functional outcomes in neurological, geriatric and psychiatric disorders: a systematic review

   • Edoardo Nicolò Aiello
   • Alfonsina D’Iorio
   • Gabriella Santangelo

   Review Article Open access 06 August 2022 Pages: 6189 - 6214

   

7. Infectious diseases and cognition: do we have to worry?

   • Virgilio Hernandez-Ruiz
   • Luc Letenneur
   • Hélène Amieva

   Review Article 22 July 2022 Pages: 6215 - 6224

   

8. Research progress in the early diagnosis of Parkinson’s disease

   • LinLin Xie
   • LuDong Hu

   Review Article 11 August 2022 Pages: 6225 - 6231

   

9. High-dose versus low-dose inhaled levodopa (CVT-301) in patients with Parkinson disease for the treatment of OFF episodes: a meta-analysis of randomized controlled trials

   • Zeya Yan
   • Wei Wang
   • Gang Chen

   Review Article 30 July 2022 Pages: 6233 - 6241

   

10. Intravenous thrombolysis before mechanical thrombectomy for acute ischemic stroke due to large vessel occlusion; should we cross that bridge? A systematic review and meta-analysis of 36,123 patients

    • Hazem S. Ghaith
    • Mohamed Elfil
    • Ahmed Negida

    Review Article 23 July 2022 Pages: 6243 - 6269

    

11. Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis

    • Isabelle Pastor Bandeira
    • André Eduardo de Almeida Franzoi
    • Marcus Vinícius Magno Gonçalves

    Review Article 18 July 2022 Pages: 6271 - 6278

    

12. Research progress on oxidative stress regulating different types of neuronal death caused by epileptic seizures

    • Haogang Sun
    • Xinxin Li
    • Songyan Liu

    Review Article 04 August 2022 Pages: 6279 - 6298

    

13. Elusive amines: migraine depends on biochemical abnormalities

    • Giovanni D’Andrea
    • Antonina Gucciardi
    • Alberta Leon

    Review Article 16 July 2022 Pages: 6299 - 6304

    

14. Emotional facial palsy: an unusual and rarely explored neurological sign

    • Giuseppina Miele
    • Luigi Lavorgna
    • Gianmarco Abbadessa

    Review Article Open access 11 July 2022 Pages: 6305 - 6307

15. The role of amyloid β in the pathological mechanism of GNE myopathy

    • Tongtong Zhang
    • Ren Shang
    • Jing Miao

    Review Article Open access 29 July 2022 Pages: 6309 - 6321

    

16. The association between urinary pentosidine levels and cognition in drug-naïve patients with Parkinson’s disease

    • Shusaku Omoto
    • Mitsuru Saito
    • Yasuyuki Iguchi

    Original Article 12 August 2022 Pages: 6323 - 6328

    

17. Prevalence and associated factors of frailty and sarcopenia in multiple system atrophy and progressive supranuclear palsy: a cross-sectional study

    • Dan Xie
    • Hongyan Huang
    • Yanming Xu

    Original Article 16 August 2022 Pages: 6329 - 6337

18. Clinical correlates of movement disorders in adult Niemann-Pick type C patients measured via a Personal KinetiGraph

    • Shaddy El-Masri
    • Charles B. Malpas
    • Mark Walterfang

    Original Article Open access 09 August 2022 Pages: 6339 - 6347

    

19. The Dutch Oxford Cognitive Screen (OCS-NL): psychometric properties in Flemish stroke survivors

    • Hanne Huygelier
    • Brenda Schraepen
    • Céline R. Gillebert

    Original Article 16 August 2022 Pages: 6349 - 6358

    

20. Rare stroke mechanisms in 4154 consecutive patients: causes, predictors, treatment, and outcomes

    • Alex Vicino
    • Gaia Sirimarco
    • Patrik Michel

    Original Article Open access 22 August 2022 Pages: 6359 - 6369

    

21. Interpretable machine learning model to predict rupture of small intracranial aneurysms and facilitate clinical decision

    • WeiGen Xiong
    • TingTing Chen
    • ZhiHong Zhao

    Original Article 23 August 2022 Pages: 6371 - 6379

    

22. Diagnosis, treatment, and follow-up of patients with cerebral amyloid angiopathy-related inflammation

    • Virginia Cancelloni
    • Alessandra Rufa
    • Alfonso Cerase

    Original Article Open access 05 August 2022 Pages: 6381 - 6387

    

23. Identification of a novel LATS1 variant associated with familial cerebral cavernous malformations in a Chinese family

    • Liangyuan Geng
    • Tao Jiang
    • Hongyi Liu

    Original Article 19 August 2022 Pages: 6389 - 6397

    

24. Predictors of flow diverter stent in large and giant unruptured intracranial aneurysms, single-center experience

    • Hazem Abdelkhalek
    • Esam Ahmed Abdelhameed
    • Islam El Malky

    Original Article Open access 19 August 2022 Pages: 6399 - 6405

    

25. Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy)

    • Daiana Bezzini
    • Elisa Gualdani
    • Monica Ulivelli

    Original Article Open access 18 August 2022 Pages: 6407 - 6414

    

26. Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study

    • Damiano Baroncini
    • Angelo Ghezzi
    • MS Study Group of the Italian Neurological Society

    Original Article 04 July 2022 Pages: 6415 - 6423

    

27. Changes of retinal structure and visual function in patients with demyelinating transverse myelitis

    • Jang Ho Lee
    • Yeji Moon
    • Jae Ho Jung

    Original Article 08 August 2022 Pages: 6425 - 6431

    

28. Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia by a novel mutation of the CSF1R gene

    • Cong Ding
    • Li Zhao
    • Chunbo Dong

    Original Article 16 August 2022 Pages: 6433 - 6440

    

29. Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments

    • Federico Massa
    • Diego Franciotta
    • Luana Benedetti

    Original Article Open access 11 August 2022 Pages: 6441 - 6447

    

30. Characteristics and management of Susac syndrome in an emergent country: a multi-center case series from Brazil

    • Igor Bessa Santiago
    • Abraão Lazaro Meneses Araújo
    • Paulo Ribeiro Nóbrega

    Original Article 09 August 2022 Pages: 6449 - 6460

    

31. Factors affecting hospitalization, imaging severity, and complications in posterior reversible encephalopathy syndrome

    • Shivaprakash B. Hiremath
    • Karine Massicotte-Tisluck
    • Santanu Chakraborty

    Original Article 19 July 2022 Pages: 6461 - 6470

    

32. Effect of current conduction for local epileptiform discharges in patients with temporal lobe epilepsy

    • Shaohui Zhang
    • Yangshuo Wang
    • Shuli Liang

    Original Article 13 August 2022 Pages: 6471 - 6478

    

33. Ketogenic diet in refractory migraine: possible efficacy and role of ketone bodies—a pilot experience

    • Carlo Lovati
    • Caterina Mariotti d’Alessandro
    • Leonardo Pantoni

    Original Article 11 August 2022 Pages: 6479 - 6485

    

34. Insomnia in primary care: a survey conducted on Italian patients older than 50 years—results from the “Sonno e Salute” study

    • Paola Proserpio
    • Giovanni Biggio
    • Dario Arnaldi

    Original Article 04 August 2022 Pages: 6487 - 6494

    

35. Alterations in functional connectivity and interactions in resting-state networks in female patients with functional constipation

    • Lei Zhang
    • Guanya Li
    • Yongzhan Nie

    Original Article 15 July 2022 Pages: 6495 - 6504

    

36. Muscle and skin fibroblast TDP-43 expression, dynamic mutation analysis of NOTCH2NLC and C9orf72 in patients with FOSMN

    • Zhuoting Liu
    • Xia Guo
    • Fei Xiao

    Original Article 16 August 2022 Pages: 6505 - 6510

    

37. Six-month outcomes in patients with hemorrhagic and non-hemorrhagic traumatic disorders of consciousness

    • Sergio Bagnato
    • Maria Enza D’Ippolito
    • Maria Andriolo

    Original Article 17 August 2022 Pages: 6511 - 6516

    

38. GM2 gangliosidosis AB variant: first case of late onset and review of the literature

    • Benjamin Ganne
    • Benjamin Dauriat
    • Sylvie Bourthoumieu

    Original Article 04 August 2022 Pages: 6517 - 6527

    

39. Pathogenic correlation between mosaic variegated aneuploidy 1 (MVA1) and a novel BUB1B variant: a reappraisal of a severe syndrome

    • Piero Pavone
    • Xena Giada Pappalardo
    • Martino Ruggieri

    Original Article Open access 09 July 2022 Pages: 6529 - 6538

    

40. Eye movement abnormalities in neurodegenerative langerhans cell histiocytosis

    • Lila Autier
    • Bertrand Gaymard
    • Ahmed Idbaih

    Original Article 28 June 2022 Pages: 6539 - 6546

    

41. A + T ± status across MCI and dementia due to AD: a clinic-based, retrospective study

    • Federico Verde
    • Edoardo Nicolò Aiello
    • Vincenzo Silani

    Brief Communication 16 August 2022 Pages: 6547 - 6550

    

42. Absence of diffusion-weighted imaging abnormalities in a patient with neuronal intranuclear inclusion disease

    • Keisuke Mizutani
    • Keita Sakurai
    • Noriyuki Matsukawa

    Brief Communication 15 July 2022 Pages: 6551 - 6554

    

43. Sinus arrest following acute lateral medullary infarction

    • Taha K. Alloush
    • Adel T. Alloush
    • Hossam M. Shokri

    Brief Communication Open access 04 August 2022 Pages: 6555 - 6559

    

44. Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis

    • Michele Corrado
    • Chiara Demartini
    • Roberto De Icco

    Brief Communication Open access 12 August 2022 Pages: 6561 - 6564

45. Nutraceuticals and migraine: further strategy for the treatment of specific conditions

    • Simone Quintana
    • Marco Russo
    • Paola Torelli

    Brief Communication 06 July 2022 Pages: 6565 - 6567

46. Painful legs and moving toes syndrome associated with dementia with Lewy bodies responsive to rotigotine-induced analgesia

    • Yuta Madokoro
    • Masayuki Mizuno
    • Noriyuki Matsukawa

    Letter to the Editor 20 July 2022 Pages: 6569 - 6570

47. An unusual ALS onset with hyperhidrosis as first clinical manifestation

    • Alessia Giugno
    • Rita Nisticò
    • Paola Valentino

    Letter to the Editor 30 July 2022 Pages: 6571 - 6572

    

48. Late seizures following cerebral venous thrombosis—may be a maladaptive attempt to release gravitational ischemia in the brain

    • J. Howard Jaster
    • Giulia Ottaviani

    Letter to the Editor 11 July 2022 Pages: 6573 - 6574

49. Ictal, intercritical and post-ictal CT perfusion in non-convulsive status epilepticus

    • Elena Merli
    • Simone Galluzzo
    • Andrea Zini

    Letter to the Editor 06 July 2022 Pages: 6575 - 6577

    

50. Lichenoid eruption: a hitherto unknown side effect of levetiracetam

    • Navya Anna Paul
    • Ramesh Bhat M
    • Sukumar D

    Letter to the Editor 16 July 2022 Pages: 6579 - 6581